Juraj Chudej
Martin, ZI, Slovakia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Ixazomib, lenalidomide, and dexamethasone combination in "real-world" clinical practice in patients with relapsed/refractory multiple myeloma.
Journal: Annals of hematology
Published: June 21, 2021
Real-world effectiveness and safety of daratumumab, bortezomib and dexamethasone in relapsed/refractory multiple myeloma in Slovakia.
Journal: Neoplasma
Published: November 13, 2020
Heparin induced thrombocytopenia and up to date options of treatment - review of literature.
Journal: Vnitrni lekarstvi
Published: January 01, 2020
Inherited thrombophilia in a patient with colorectal carcinoma.
Journal: Przeglad gastroenterologiczny
Published: April 15, 2019
Prothrombin gene 20210A mutation in Slovak population.
Journal: Vnitrni lekarstvi
Published: June 03, 2016
Endovascular stenting in malignant obstruction of superior vena cava.
Journal: International journal of surgery case reports
Published: March 19, 2015
Differential impact of bortezomib on HL-60 and K562 cells.
Journal: General physiology and biophysics
Published: July 22, 2014
Current survival measures reliably reflect modern sequential treatment in CML: correlation with prognostic stratifications.
Journal: American journal of hematology
Published: May 31, 2013
Evaluation of 5-year imatinib treatment of 458 patients with CP-CML in routine clinical practice and prognostic impact of different BCR-ABL cutoff levels.
Journal: Cancer medicine
Published: October 29, 2012
Five year-results of chemoresistance testing in cancer patients
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: January 20, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026